IOP
Recent news mentioning IOP
- — Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- — Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
- — Inductive Launches Beacon-2, Making Human Dose Computable for Chemists and AI Agents Across Biopharma
- — Condor Software Unveils World's First Clinical Finance AI Agent Purpose-Built for Biopharma R&D
- — Ernexa Therapeutics Appoints Accomplished Biopharmaceutical Executive Robert J. Spiegel, M.D., FACP, to Board of Directors
- — GBI Biomanufacturing to Launch SmartScale™ GMP Solutions at BioProcess International East 2026
- — Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
- — Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026
- — Innerspace Counseling Recognized as Best Specialized Mental Health IOP and PHP Services in New Jersey
- — ISPE Announces Keynote Speakers for its 2026 ISPE Pharma 4.0™ and Biopharma Conference
- — Propanc Biopharma Positions PRP’s EMT-Reversal Mechanism as a Complementary Backbone to Emerging RAS Inhibitors from Revolution Medicines, Inc. and Erasca, Inc.
- — PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor